Embolotherapy Market: Comprehensive Analysis and Growth Opportunities To 2028
Emergen Research Logo
Market Size – USD 3.50 Billion in 2020, Market Growth – at a CAGR of 9.3%, Market Trends –Increasing development of new endovascular treatment procedures
VANCOUVER, BRITISH COLUMBIA, CANADA, June 29, 2023/EINPresswire.com/ -- The global embolotherapy market size reached USD 3.50 Billion in 2020 and is expected to register a revenue CAGR of 9.3% during the forecast period, according to the latest analysis by Emergen Research. The increasing prevalence of chronic diseases such as cancer, peripheral artery disease, and neurological disorders, among others, is a key factor driving global embolotherapy market revenue growth. A steady transition towards minimally invasive procedures from invasive open surgical procedures is expected to continue to drive revenue growth in the global embolotherapy market. Increasing demand for image-guided minimally invasive interventions has not only broadened the scope of vascular pathologies that can be treated but has also resulted in a reduction of post-operative morbidity compared to open surgical techniques. Embolization is an advanced form of treatment option whereby tiny equipment is used to navigate the body’s vasculature without the need for a wound incision or open surgery. This enables reduced complication rates, increases success rates, and improves the quality of life of patients.
Embolotherapy is commonly used in the treatment of tumors, vascular malformations, and aneurysms. The procedure typically involves the injection of embolic agents, such as microspheres, coils, or liquid embolic agents, into the blood vessels supplying the affected area. These agents block the blood flow to the targeted tissue, leading to its shrinkage or elimination.
One of the key advantages of embolotherapy is its minimally invasive nature, which reduces the risk and complications associated with traditional surgical procedures. It offers a less traumatic alternative, allowing for quicker recovery times and shorter hospital stays.
The embolotherapy market has witnessed significant growth in recent years, driven by advancements in medical technology, increasing prevalence of diseases requiring embolization, and rising demand for minimally invasive treatment options. The market is supported by the development of innovative embolic agents, improved imaging techniques, and the availability of skilled healthcare professionals proficient in performing embolotherapy procedures.
To receive a sample copy of this report, visit @ https://www.emergenresearch.com/request-sample/763
The study outlines the rapidly evolving and growing market segments along with valuable insights into each element of the industry. The industry has witnessed the entry of several new players, and the report aims to deliver insightful information about their transition and growth in the market. Mergers, acquisitions, partnerships, agreements, product launches, and joint ventures are all outlined in the report.
The leading market contenders listed in the report are:
Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Terumo Medical Corporation, Penumbra Inc., Johnson & Johnson, Merit Medical Systems Inc., Cook Medical Inc., Kaneka Corporation, and Stryker Corporation
Target Audience of the Global Embolotherapy Market Report:
Key Market Players
Investors
Venture capitalists
Small- and medium-sized and large enterprises
Third-party knowledge providers
Value-Added Resellers (VARs)
Global market producers, distributors, traders, and suppliers
Research organizations, consulting companies, and various alliances interested in this sector
Government bodies, independent regulatory authorities, and policymakers
Get a discount on the Global Embolotherapy Market report @ https://www.emergenresearch.com/request-discount/763
Major Geographies Analyzed in the Report:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Market Segmentations of the Embolotherapy Market
This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2021 and 2028. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Embolotherapy market on the basis of product, application, and region:
Segments Covered in this report are:
Product Outlook (Revenue, USD Billion; 2018–2028)
Embolic Agents
Liquid Embolic Agents
Microspheres
Embolization Coils
Detachable Coils
Pushable Coils
Detachable Balloons
Embolic Plug Systems
Support Devices
Microcatheters
Guidewires
Procedure Outlook (Revenue, USD Billion; 2018–2028)
Transcatheter Arterial Embolization
Transcatheter Arterial Radioembolization
Transcatheter Chemoembolization
Application Outlook (Revenue, USD Billion; 2018–2028)
Cancer
Peripheral Vascular Disease
Neurological Disease
Urological & Nephrological Disorders
Others
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.emergenresearch.com/industry-report/embolotherapy-market
Some Key Highlights from the Report
Embolic agents segment is expected to account for largest revenue share over the forecast period due to increasing use of calibrated microscopes, biodegradable microspherical embolic agents and increasing development of next generation liquid embolics for facilitating treatment of a variety of pathological disease.
Transcatheter arterial radioembolization segment revenue is expected to expand at a rapid CAGR over the forecast period owing to rising popularity of this therapeutic modality for effectively treating both primary and secondary hepatobilary disease and increasing investment to develop next generation radioembolic devices to improve clinical outcomes.
Cancer segment is expected to account for largest revenue share over the forecast period owing to rising prevalence of liver cancer and increasing number of transarterial chemoembolization procedures performed for controlling tumor growth and destroying cancer cells and providing quality care to patients suffering with liver cancer.
Ambulatory surgical segment is expected to register a significantly robust CAGR in terms of revenue over the forecast period due to increasing preference for outpatient surgical procedures, increasing patient admissions in these facilities, availability of reimbursement, and increasing number of embolotherapy surgical procedures performed at these facilities.
North America is expected to account largest revenue share over the forecast period due to rising number of clinical trials for assessing safety and efficacy of embolization in a wide range of applications and increasing use of Drug-Elating Bead Transarterial Chemoembolization (DEB-TACE)
Additional information offered by the report:
Along with a complete overview of the global Embolotherapy market, the report provides detailed scrutiny of the diverse market trends observed on both regional and global levels.
The report elaborates on the global Embolotherapy market size and share governed by the major geographies.
It performs a precise market growth forecast analysis, cost analysis, and a study of the micro- and macro-economic indicators.
It further presents a detailed description of the company profiles of the key market contenders.
Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/763
Thank you for reading our report. Customization of the report is available according to the requirements of our clients. Kindly get in touch with us to know more about the customization options, and our team will ensure the report is tailored according to your needs.
Latest Published Reports by Emergen Research:
Adaptive Learning Market
Aerospace 3D Printing Market
Healthcare Customer Relationship Management (CRM) Market
Medical Device Connectivity Market
Fiberglass Market
Legal Online Dispute Resolution Market
https://prtimes.jp/main/html/rd/p/000000012.000082259.html
Insulation market
https://prtimes.jp/main/html/rd/p/000000101.000082259.html
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Eric Lee
Emergen Research
+91 90210 91709
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
